INDEX
Volume 252, January-March, 1990
A-64662, renin inhibition, renal hemody-namic and excretory responses (mon-
keys), 449Aass, H., see Skomedal, T., 853Abed, J. F., see Gruber, S. A., 733Abraham, R. T., see Oakes, S. G., 979Abrahamsson, T., see Nerme, V., 1341Acara, M., see Lohr, J., 154Acetaminophen
hepatotoxicity, methylxanthines, induc-
tion states (rats), 112
intestinal glucuronidation and sulfation
(rats), 201metabolites, altered hepatobiliary dispo-
sition, phenobarbital pretreatment(rats), 657
Acetylcholine
basal release, muscarinic receptor block-ade (rats), 739
contractile response to bombesin, longi-tudinal muscle, ileum (guinea pigs),339
inhibition of contractions but not relaxa-
tions, pertussis toxin, pulmonary ar-tery (rabbits), 260
rate perfusion pressure, substance P(guinea pigs), 179
release, inhibition from neocortex, co-con-otoxin GVIA (humans), 778
N-Acetyl--y-glutamyl prodrug, renal selec-tivity,1255
Adeagbo, A. S. 0., Breen, C. A., Cutz, E.,Lees, J. G., Olley, P. M. and Coceani,F.: Lamb ductus venosus: Evidenceof a cytochrome P-450 mechanism inits contractile tension, 875
Adeagbo, A. S. 0. and Malik, K. U.: Mech-anism of vascular actions of prosta-
cyclin in the rat isolated perfusedmesenteric arteries, 26
Adenine nucleosides, nucleotides and, nerve
and drug-induced release, aorta (rab-bits), 1060
Adenosine, angiotensin II and, vasocon-strictor response, hypertonic saline
infusions (dogs), 631
Adenosine monophosphate, cyclic, seeCyclic AMP
Adenylate cyclasebeta-2 adrenoceptor-mediated vasodila-
tion, aorta, clenbuterol treatment(rats), 758
coupling, beta adrenoceptor binding, pul-monary artery vs. aorta (rats), 86
desimipramine and lithium, serotonergicreceptor number, second messenger
function in brain (rats), 826
inhibition, muscarinic receptor subtypes,
myometrium (guinea pigs), 800intracellular cyclic AMP content, chronic
ethanol exposure, PC 12 cells, 1021mouse neuroblastoma x rat glioma hybrid
cells, cAMP accumulation, musca-
rinic cholinergic receptors, 616
prolonged reserpine treatment, adapta-
tive mechanisms, dopamine Dl and
D2 receptors (mice), 810
role of membrane lipid order, tetrahydro-
cannabinol, heart (rats), 1075Adham, N., see Blue, D. R., 1034Adler, M. W., see Tiseo, P. J., 539Adrenal medulla, effect of quinpirole, sym-
pathoadrenal system (dogs), 770Adrenoceptors
alphaaging, norepinephrine release (rats),
159
sympathetic control, proximal urethra(rats), 706
alpha-2, evidence for G-protein precou-pling (cows), 1184
alpha-2 Aadenylate cyclase coupling, pulmonary
artery vs. aorta (rats), 86antagonist characterization, ileum
(guinea pigs), 1034characterization, fats cells (humans),
312 betaG,-coupling, isoproterenol (guinea
pigs), 1341neural adaptation, imipramine (rats),
997prenatal propanolol exposure, fetal and
neonatal lung (rats), 42supersensitivity, right atria in early
sepsis (rats), 675beta-2, vasodilation in aorta, clenbuterol
(rats),758Adrenocorticotropic hormone, plasma,
fourth cerebroventricle, nicotine(rats), 623
AG-1749, inhibition of acid formation,mechanism, parietal cells (dogs),
1289Aging
ethanol consumption and, muscarinic
cholinergic receptors, brain (rats),869
prejunctional modulation, norepineph-rine release (rats), 159
-related changes in relaxant response,atrial natriuretic peptide, vascular
smooth muscle (rats), 1234Ahmad, S. and Ward, P. E.: Role of amino-
peptidase activity in the regulation of
the pressor activity of circulating an-giotensins, 643
Airwaypotassium channel activator, excitatory
noncholinergic and cholinergic neu-rotransmission (guinea pigs), 1207
potentiation of nonadrenergic neural re-
laxation, cAMP phosphodiesteraseinhibitor (guinea pigs), 396
Albumin, intratubular, furosemide-A mech-
anism, diuretic resistance in ne-
phrotic syndrome (rats), 1097
Albuquerque, E. X., see Costa, A. C. S., 507Albuquerque, E. X., see Kofuji, P., 517Alcohol, castration-induced changes in re-
sponse, hypothalamic-pituitary axis(rats), 456
Aldosterone, carbon tetrachloride-induced
cirrhosis (rats), 438
Alkaloids, Veratrum, nerve stimulation, iontransport in jejunum (mice), 636
Allen, C. N., see Bigornia, L., 586Allergy, dual antagonist, platelet-activating
factor and histamine, SCH 37370(guinea pigs), 1090
Allografts, renal model, pharmacodynamics,
local heparin infusion (dogs), 733Aiprenolol, antagonist characterization,
atypical beta adrenoceptors (guineapigs), 1034
Althaus, W. A., see Lindstrom, T. D., 1117Amiloride, imidazoline-guanidinium recep-
tive site, renal proximal tubule (rab-
bits), 293Amine, neural adaptation, imipramine,
forced swim test (rats), 997
-y-Aminobutyric acid
antagonism of GABAA receptor, amino--y-carbolines (mice), 1269
contractile response to bombesin, longi-tudinal muscle, ileum (guinea pigs),
339evoked release from striatal neurons,
NMDA receptor system (mice), 380Amino--y-carbolines, antagonism of -y-ami-
nobutyric acidA receptor (mice), 1269
p-Aminohippurate, transport in brush bor-der membrane, kidney (pigs), 792
Aminopeptidase, regulation of pressor activ-
ity, circulating angiotensins, 643
D-Amphetamine, fenfluramine and, toler-
ance, food intake (baboons), 960Analgesia
differential release, substance P and so-matostatin, spinal cord (rats), 539
E-2078 (mice), 1247morphine withdrawal
mu antagonist and kappa agonist prop-erties of �-funaltrexamine (rats),
1006SCH 23390 labeling, dopamine D1 re-
ceptors (rats), 901 spinal
Anatoxin-a, acetylcholine receptor-ion
channel, activation and blockade
(frogs),517Anderson, D. C., see Shappell, S. B., 531Anderson, J., see Malfroy, B., 462Anesthesia, urethane, duodenal motility,
cholecystokinin-octapeptide (rats),
1312
Angiogenesis, basement membrane biosyn-
thesis, target, tumor therapy, 753Angiotensin-converting enzyme, inhibitors,
biliary excretion, conjugation (rats),1202
Angiotensin IIadenosine and, vasoconstrictor response,
hypertonic saline infusions (dogs),
631-induced contractions, endogenous pros-
1387
1388 Index Vol. 252
taglandins, cerebral and mesenteric
arteries (dogs, monkeys), 374mechanism of action, proximal tubular
transport (rats), 689
tachyphylaxis to vasoconstrictor effect,arachidonic acid, kidney (rats), 241
Angiotensins, circulating, regulation ofpressor activity, aminopeptidase, 643
Anion, tachykinin-induced secretion, distal
colon (guinea pigs), 1Ansari, M. A., see Elias, A. N., 384Antidepressants
binding sites in brain (rats), 410
desimipramine and lithium, serotonergicreceptor number, second messengerfunction in brain (rats), 826
Antihypertensive agents, DuP 753, nonpep-
tide angiotensin II receptor antago-
nists (rats), 711, 719, 726Antinociception
inhibition of tail-flick response, f3-endor-
phin, morphine (rats), 546
parathyroid hormone peptide fragments,salmon calcitonin, morphine (mice),140
Aorta
adenylate cyclase coupling, beta adreno-ceptor binding (rats), 86
alpha-2 receptors, receptor G-protein cou-pling (cows), 1184
beta-2 adrenoceptor-mediated vasodila-tion, clenbuterol treatment (rats),
758
endothelial cells, cyclic GMP production,bradykinin (porcine), 581
nerve and drug-induced release, adeninenucleosides, nucleotides (rabbits),
1060receptor-mediated mutual-effect amplifi-
cation, phenylephrine and serotonin(rabbits), 500
thromboxane A2/prostaglandin H2 recep-
tor, vasoconstrictor response, endo-thelin (rats), 915
Aoyama, T., see Relling, M. V., 442Aracava, Y., see Costa, A. C. S., 507
Aracava, Y., see Kofuji, P., 517Arachidonic acid
indomethacin effects on neural and my-ogenic components, airway smoothmuscle (horses), 358
tachyphylaxis to vasoconstrictor effect,kidney (rats), 241
Arendt, J., see Welch, S. P., 370Arginine vasopressin, carbon tetrachloride-
induced cirrhosis (rats), 438Aronstam, R. S., see Costa, A. C. S., 507Aronstam, R. S., see Kofuji, P., 517Arrhythmia, cocaine-mediated impairment,
cardiac conduction (dogs), 185Artery
cerebral, endothelium-dependent vaso-
constriction, membrane depolariza-tion (cats), 93
cerebral and mesenteric, endogenousprostaglandins, angiotensin Il-in-
duced contractions (dogs, monkeys),374
contraction, Rb-86 efflux, BRL-34915(rats), 51
coronary
binding and functional studies, musca-rinic cholinoceptors (porcine), 765
calcium channel receptor sites, PN 200-110 (pigs), 327
endothelium effects, basal tone and ag-
onist (pigs), 1053
5-hydroxytryptamine-induced endo-thelium-dependent relaxation (pigs),
387receptor systems, epidermal growth fac-
tor-urogastrone (porcine, bovine),
1277
different tissues, 5-HT2 receptor hetero-geneity (rats, rabbits), 1083
inositol phosphate production, effect ofH-7, crossbridge phosphorylation
(rabbits), 253mesenteric
mechanism of vascular actions, prosta-
cyclin (rats), 26
smooth muscle sensitivity, calcium an-
tagonists (rabbits), 1167
pimobendan effects (rats), 1304pulmonary
adenylate cyclase coupling, beta adre-noceptor binding (rats), 86
endothelin-induced contractions, pina-
cidil antagonism (guinea pigs, rats),
1318
inhibition of contractions, pertussis
toxin (rabbits), 260
Na7K�-adenosine triphosphatase,monocrotaline (rats), 70
Arthritis, biologic properties of romazarit
(rats), 1331
Ashby, C. R., Jr., Jiang, L. H., Kasser, R. J.and Wang, R. Y.: Electrophysiologi-
cal characterization of 5-hydroxytryptamine2 receptors in therat medial prefrontal cortex, 171
Assays, spectrophotometric and biological,nitric oxide endothelium-derived re-
laxing factor, 922Asthma, potassium channel activator, excit-
atory noncholinergic and cholinergicneurotransmission (guinea pigs),
1207Atlas, D., see Coupry, I., 293Atria, right, supersensitivity, beta adre-
noceptors (rats), 675
Atrial natriuretic peptide
age-related changes in relaxant response,vascular smooth muscles (rats), 1234
carbon tetrachloride-induced cirrhosis
(rats), 438
cyclooxygenase products, modulation ofrenal response, endothelin (rats),1213
Atropine, rate perfusion pressure, substance
P (guinea pigs), 179Austin, M. C. and Kalivas, P. W.: Enke-
phalinergic and GABAergic modula-
tion of motor activity in the ventral
pallidum, 1370Autoradiography
antidepressant binding sites in brain(rats), 410
cellular localization of serotonin 1A,1B,cingulate cortex, uptake sites (rats),
651peripheral type benzodiazepine receptors,
lung (guinea pigs), 880
Ayaziki, K., see Toda, N., 374Azepexole, halothane and, pertussis toxin
effect (guinea pigs), 1156
Bachenheimer, L. C., see Jam, R. K., 147
Baker, R. C., Tucker, M. and Clay, K. L.:Ethanol inhibits zymosan-stimulated
and enhances nonstimulated plate-let-activating factor production in a
clonal macrophage cell line, 1028
Baister, R. L., see Beardsley, P. M., 953Barker, L. A., Winbery, S. L., Smith, L. W.
and McDonough, K. H.: Supersensi-tivity and changes in the active pop-
ulation of Beta adrenoceptors in ratright atria in early sepsis, 675
Barnes, P. J., see Chilvers, E. R., 786
Barnes, P. J., see Ichinose, M., 1207Barnes, P. J., see Mak, J. C. W., 880Barnes, P. J., see Rhoden, K. J., 396Barnette, M. S., Grous, M., Torphy, T. J.
and Ormsbee, H. S., III: Activation
of cyclic AMP-dependent protein ki-nase during canine lower esophageal
sphincter relaxation, 1160
Barrington, P. L. and Ten Eick, R. E.: Char-
acterization of the electrophysiologi-
cal effects of metoprolol on isolatedfeline ventricular myocytes, 1043
Basement membrane, biosynthesis, target,
tumor therapy, 753Bass, P., see Herman, J. R., 135
Batty, I. H., see Chilvers, E. R., 786
Baughman, R., see Malfroy, B., 462Beardsley, P. M., Hayes, B. A. and Balster,
R. L.: The self-administration ofMK-801 can depend upon drug-rein-forcement history and its discrimi-
native stimulus properties are phen-cyclidine-like in rhesus monkeys, 953
Behavior
drug-reinforcement history, self-adminis-
tration, MK-801 (monkeys), 953
enhanced sensitivity, naltrexone (rats), 8
low-dose caffeine discrimination (hu-mans), 970
phencyclidine-like, NMDA-induced con-
vulsions, NMDA and glycine antag-onists (mice), 349
smoked marijuana effects, tobacco ciga-rette smoking behavior (humans),
934
thermoregulatory set point, opioid ago-nists (rats), 696
Benet, L. Z., see Smith, P. C., 218Benzamide, sodium-dependent isomeriza-
tion, dopamine D-2 receptors, epide-
pride, 1108
Benzimidazole, inhibition of acid formation,AG-1749, parietal cells (dogs), 1289
Benzodiazepines, midazolam, tolerance and
physical dependence (rats), 1125
Berlan, M., see Galitzky, J., 312Bestatin, transport mechanisms, intestinal
brush-border membranes (rabbits),859
Betaine, disposition of choline, dimethylam-inoethanol, kidney (rats), 154
Bhargava, H. N. and Gulati, A.: Modifica-tion of brain and spinal cord dopa-
mine D1 receptors labeled with [3H]SCH 23390 after morphine with-drawal from tolerant and physically
dependent rats, 901
Bicarbonate, water secretion, gabexate and
camostat, pancreas (dogs), 320Bigornia, L., Allen, C. N., Jan, C.-R., Lyon,
R. A., Titeler, M. and Schneider, A.S.: D2 dopamine receptors modulate
calcium channel currents and cat-
echolamine secretion in bovine adre-
nal chromaffin cells, 586
1990 Index 1389
Bilder, G. E., Kasiewski, C. J. and Perrone,M. H.: Phorbol-12,13-dibutyrate-in-duced vasoconstriction in Vivo:Characterization of response in ge-netic hypertension, 526
Biliary excretion, conjugation and, diacid
angiotensin-converting enzyme in-
hibitors (rats), 1202
Billah, M. M., Chapman, R. W., Egan, R.W., Gilchrest, H., Piwinski, J. J.,Sherwood, J., Siegel, M. I., West, R.
E., Jr. and Kreutner, W.: Sch 37370:A potent, orally active, dual antago-nist of platelet-activating factor andhistamine, 1090
Bitran, J. A., see Gusovsky, F., 466Bjur, R. A., see Sedaa, K. 0., 1060Blanchard, S. M., see Kabas, J. S., 185Blood pressure, mediation of tachycardia, 5-
hydroxytryptamine, receptors (dogs),683
Bloom, A. S., see Hillard, C. J., 1075Bloxham, D. P., Bradshaw, D., Cashin, C.
H., Dodge, B. B., Lewis, E. J., West-macott, D. and Self, C. R.: Biologicproperties of Romazarit (Ro 31-
3948), a potential disease-modifyingantirheumatic drug, 1331
Blue, D. R., Bond, R. A., Adham, N., Del-mendo, R., Michel, A. D., Elgen, R.M., Whiting, R. L. and Clarke, D. E.:Antagonist characterization of “atyp-
ical” beta adrenoceptors in guinea pigileum: Blockade by alprenolol and
dihydroalprenolol, 10, 34Boarder, M. R., see Plevin, R., 1296Boisse, N. R., Quaglietta, N., Samoriski, G.
M. and Guarino, J. J.: Tolerance andphysical dependence to an ultra-
short-acting benzodiazepine, mida-zolam, 1125
Bombesin, mechanism of contractile re-sponse, longitudinal muscle, ileum
(guinea pigs), 339
Bond, R. A., see Blue, D. R., 1034Boulanger, C., see Schini, V. B., 581
Bowers, R. J., see Shubat, P. J., 70Boyer, D. R., see Hillard, C. J., 1075Bradshaw, D., see Bloxham, D. P., 1331Brady, J. V., see Kelly, T. H., 934Bradycardia, rate perfusion pressure, sub-
stance P (guinea pigs), 179Bradykinin
cyclic GMP production, B2 kinin recep-tors, aortic endothelial cells (por-
cine), 581esophageal longitudinal smooth muscle
(opossums), 1012
Brainactivation of ventral medullary serotonin
receptor subtypes, cardiovascular ac-
tivity (cats), 665
antidepressant binding sites (rats), 410
basal acetyicholine release, muscarinic re-
ceptor blockade (rats), 739cingulate cortex, cellular localization, Se-
rotonin 1A,1B (rats), 651dopamine D receptors, SCH 23390 label-
ing, morphine withdrawal (rats), 901dopaminergic and serotonergic mecha-
nisms, SCH 23390 and haloperidol(rats), 845
5-HT1, receptors, G -protein-linked sero-tonin receptors, kidney (mice), 1347
hypothalamic-pituitary axis, castration-induced changes, alcohol (rats), 456
medial prefrontal cortex, characteriza-tion, 5-hydroxytryptamine2 receptors(rats), 171
modulation of mesoprefrontal dopamine
neurons, central benzodiazepine re-
ceptors, 989
muscarinic cholinergic receptors, ethanol
consumption and aging (rats), 869role of fourth cerebroventricle, plasma
ACTH responses, nicotine (rats), 623second messenger function, serotonergic
receptor number, desimipramine and
lithium (rats), 826
substantia nigra and nucleus caudate,neurotensin-induced dopamine re-
lease (rabbits), 817
synaptosomes, sodium-dependent release,dopamine and noradrenaline (rats),1283
ventral pallidum, enkephalinergic and
GABAergic modulation, motor activ-
ity (rats), 1370
Branch, R. A., see Deray, G., 631Brater, D. C., see Kirchner, K. A., 1097Breeding, M., see Sanders-Bush, E., 984Breen, C. A., see Adeagbo, A. S. 0., 875Breese, G. R., Criswell, H. E., McQuade, R.
D., Iorio, L. C. and Mueller, R. A.:Pharmacological evaluation of SCH-
12679: Evidence for an in Vivo antag-onism of D1-dopamine receptors, 558
Breese, G. R., see Paul, I. A., 997Bremazocine, differential cross-tolerance,
shock titration schedule (monkeys),
845Bridenbaugh, R., see Malfroy, B., 462
BRL 34915, see CromakalimBronchoconstriction, inhibition of reflex,
airway opioid receptors (guinea pigs),863
Brosnihan, K. B., see Chatelain, R. E., 117Brouwer, K. L. R. and Jones, J. A.: Altered
hepatobiliary disposition of acetami-nophen metabolites after phenobar-
bital pretreatment and renal ligation:Evidence for impaired bilary excre-tion and a diffusional barrier, 657
Brown, D. R., Overend, M. F. and Treder,
B. G.: Neurohormonal regulation ofion transport in the porcine distaljejunum. Actions of somatostatin-14and its natural and synthetic homo-logs, 126
Brush-border membrane
intestinal, transport mechanisms, besta-tin (rabbits), 859
urate and p-aminohippurate transport,kidney (pigs), 792
vesicles, peptidases and peptide transport(rats), 98
Buchholz, J. and Piper Duckles, S.: Effectof age on prejunctional modulation of
norepinephrine release, 159
Buckner, C. K., Fedyna, J. S., Robertson, �J.
L., Will, �J. A., England, D. M., Krell,R. D. and Saban, R.: An examinationof the influence of the epithelium oncontractile responses to peptidoleu-
kotrienes and blockade by ICI 204,219 in isolated guinea pig trachea andhuman intralobar airways, 77
Buckpitt, A., see Plopper, C., 428Buja, L. M., see Shaul, P. W., 86
Burke, B. A., see Gruber, S. A., 733Burks, T. F., see Sheldon, R. J., 636Burks, T. F., see Spencer, R. L., 696Burton, C. K., Ho, I. K. and Hoskins, B.:
Evidence for involvement of cyclicGMP phosphodiesterase in morphinetolerance, 104
BW942C, kappa opioid partial agonist activ-ity (humans, rats, mice, monkeys),225
Caffeine, low-dose, discrimination (hu-
mans), 970Calcitonin, morphine and, parathyroid hor-
mone peptide fragments, antinoci-
ceptive tests (mice), 140Calcitonin gene-related peptide, -containing
nerves, vascular adrenergic neuro-
transmission (rats), 403Calcium
antagonists, sensitivity, mesenteric arterysmooth muscle (rabbits), 1167
displacement, catamphiphilic drug up-
take, erythrocytes and muscular tis-sue (humans), 333
intracellular, block by doxorubicin,neuroblastoma cells, 979
maitotoxin-stimulated phosphoinositide
breakdown, mechanism, HL-60 cells,
466mechanisms of vascular action, parathy-
roid hormone, 840nonpeptide angiotensin II receptor antag-
onists, DuP 753 (rats), 711, 719, 726pertussis toxin and vasomotion (rabbits),
260phospholipase C, modulation of automa-
ticity, cardiac Purkinje fibers (dogs),886
sodium-dependent release of dopamine,
noradrenaline, brain synaptosomes
(rats), 1283
Calcium channelantagonists, mechanisms, gastric proton
pump inhibition (rabbits), 1102
dihydropyridine antagonists, antiseizureactivity (rats), 1150
glycine-evoked neurotransmitter release,hippocampus (rats), 574
inhibition of norepinephrine and acetyl-choline release, co-conotoxin GVIA,neocortex (humans), 778
modulation of current, D2 dopamine re-ceptors, adrenal chromaffin cells (bo-
vine), 586potent blocking action of chiorpromazine,
neuroblastoma cells (mice), 1142
receptor sites, PN 200-110, coronary ar-
tery (pigs), 327Calcium current, cromakalim actions on
ionic currents, portal vein, smooth
muscle cells (rats), 832
Caliezi, A., see Scheurer, U., 1324Camostat, gabexate and, water and bicar-
bonate secretion, pancreas (dogs),
320Campbell, E. D., see Gennings, C., 208Canafax, D. M., see Gruber, S. A., 733Capsaicin
calcitonin gene-related peptide-contain-
ing nerves, vascular adrenergic neu-rotransmission (rats), 403
-induced miosis in eye, prevention, recom-
binant enkephalinase (rabbits), 462Captopril, vasoconstrictor response, angio-
1390 Index Vol. 252
tensin II and adenosine, hypertonicsaline infusions (dogs), 631
Carbolines, antagonism of -y-aminobutyric
acidA receptor, amino--y -carbolines(mice), 1269
Cardiovascular system
activation, ventral medullary serotoninreceptor subtypes (cats), 665
cocaine effects, central and autonomicneural mechanisms (monkeys), 491
Carini,D.J.,seeChiu,A.T., 711
Carini, D. J., see Wong, P. C., 719, 726Carlen, P. L., see Reynolds, J. N., 265Carter, W. H., Jr., see Gennings, C., 208Cashin, C. H., see Bloxham, D. P., 1331Cass, W. A., see Lupica, C. R., 1134Castration, -induced changes in response to
alcohol, hypothalamic-pituitary axis
(rats), 456
Catamphiphilic drugs, uptake into erythro-cytes and muscular tissue, calciumdisplacement, phosphatidylserine
monolayers (humans), 333
Catecholamineeffect of quinpirole on sympathoadrenal
system (dogs), 770
secretion, D2 dopamine receptors, adrenalchromaffin cells (bovine), 586
Cations, organic, transport by kidney epi-
thelial cells, 286
Caudle, R. M. and Chavkin, C.: Mu opioidreceptor activation reduces inhibi-
tory postsynaptic potentials in hip-pocampal CA3 pyramidal cells of rat
and guinea pig, 1361Cavero, I., see Le Monnier de Gouville, A.
C., 300Cavero, I., see Tahraoui, L., 1221Cephalosporins, renal mitochondrial toxic-
ity (rabbits), 65Cephradine, intestinal brush-border mem-
brane, transport mechanisms, besta-tin (rabbits), 859
Cerebellar granule cells, glutamate-induced
neuronal death (rats), 419CGS 21680, electrophysiology, cAMP for-
mation, hippocampus and striatum(rats), 1134
CGS 19281A, antihypertensive effects(rats),117
Chan, Y. L., see Wang, T., 689Chao, C. C., Sharp, B. M., Pomeroy, C.,
Filice, G. A., and Peterson, P. K.:
Lethality of morphine in mice in-
fected with Toxoplasma gondii, 605Chapman, R. W., see Billah, M. M., 1090Chatelain, R. E., Manniello, M. J., Dardik,
B. N., Rizzo, M. and Brosnihan, K.B.: Antihypertensive effects of CGS19281A, an inhibitor of phenyletha-nolamine-N-methytransferase, 117
Chavkin, C., see Caudle, R. M., 1361Chekal, M. A., see Verburg, K. M., 449Cheng, H.-Y., see Hoke, G. D., 908Chiba, S., see Horiuchi, A., 320Chilvers, E. R., Batty, I. H., Barnes, P. J.
and Nahorski, S. R.: Formation ofinositol polyphosphates in airwaysmooth muscle after muscarinic re-ceptor stimulation, 786
Chiu, A. T., McCall, D. E., Price, W. A.,Wong, P. C., Carini, D. J., Duncia, J.
V., Wexler, R. R., Yoo, S. E., John-son, A. L. and Timmermans, P. B.M. W. M.: Nonpeptide angiotensin II
receptor antagonists. VII. cellular
and biochemical pharmacology ofDuP 753, an orally active antihyper-tensive agent, 711
Chiu, A. T., see Wong, P. C., 719, 726Chloride, contractile responses, ethanol and
GABAA agonists, ileum longitudinalmuscle (guinea pigs), 474
Chlorpromazine, potent blocking action,
calcium channels, neuroblastomacells (mice), 1142
Cholecystokinin-octapeptide, dual effectson duodenal motility, urethane anes-thesia (rats), 1312
Choline, disposition in kidney, dimethylam-inoethanol (rats), 154
Cholinoceptors, muscarinic, binding andfunctional studies, coronary artery(porcine), 765
Choroid plexus, serotonin,� receptor reserve,receptor subsensitivity (rats), 984
Chow, Y.-K., see Viamonte, V. M., 886Christ, G. J., Goldfarb, J. and Maayani, S.:
Receptor-mediated mutual-effectamplification elicited by phenyleph-
rine and serotonin in isolated rabbitaorta, 500
Chromaffin cellsadrenal, D2 dopamine receptors, calcium
channel currents (bovine), 586noradrenalin release, phosphoinositide
turnover, cAMP accumulation, 1296
Ciaranello, R. D., Tan, G. L. and Dean, R.:
G-protein-linked serotonin receptors
in mouse kidney exhibit identicalproperties to 5-HTh receptors inbrain, 1347
Cicero, T. J., Greenwald, J., Nock, B. and
O’Connor, L.: Castration-inducedchanges in the response of the hypo-thalamic-pituitary axis to alcohol inthe male rat, 456
Cigarette smokingeffect of nicotine dose, withdrawal-
suppression (humans), 1175
tobacco, smoked marijuana effects, be-
havior (humans), 934Cingulate cortex, cellular localization of Se-
rotonin 1A,1B, uptake sites (rats),651
Cipkus-Dubray, L. A., see Meisheri, K. D.,1167
Cipolle, R. J., see Gruber, S. A., 733Cirrhosis, carbon tetrachloride-induced,
atrial natriuretic peptide, vasopressin
and aldosterone (rats), 438Clara cells, bronchiolar necrosis from naph-
thalene, lung (mice), 428
Clarke, D. E., see Blue, D. R., 1034Clarke, D. E., see Craig, D. A., 1378Clay, K. L., see Baker, R. C., 1028Clenbuterol, beta-2 adrenoceptor-mediated
vasodilation, aorta (rats), 758Clonidine, imidazoline-guanidinium recep-
tive site, renal proximal tubule (rab-bits), 293
Cocaine
cardiovascular effects, central and auto-nomic neural mechanisms (mon-keys), 491
-mediated impairment of cardiac conduc-tion (dogs), 185
potentiation of cardiac effects, neurallyreleased norepinephrine (cats), 147
Coceani, F., see Adeagbo, A. S. 0., 875
Coene, M. -C., see van Wauwe, J. P., 365Coffman, W. J., see Wilson, H., 683
Cohen, M. L., see Wilson, H., 683Cold, noxious, differential release, sub-
stance P and somatostatin (rats), 539Colon
different motor actions, dynorphins,kappa opioid receptor agonists (rats),1324
distal, tachykinin-induced anion secre-tion (guinea pigs), 1
Colpaert, F. C., see Koek, W., 349Cone, E. J., see Vaupel, D. B., 225co-Conotoxin GVIA, inhibition of norepi-
nephrine and acetylcholine release,neocortex (humans), 778
Convulsions, NMDA-induced, NMDA and
glycine antagonists (mice), 349Cooke, H. J., see Kuwahara, A., 1
Cools, W., see van Wauwe, J. P., 365Coma, D., see Vigan#{244},G., 344Costa, A. C. S., Swanson, K. L., Aracava,
Y., Aronstam, R. S. and Albuquerque,E. X.: Molecular effects of dimethy-lanatoxin on the peripheral nicotinicacetylcholine receptor, 507
Costa, E., see Manev, H., 419Cough, inhibition, airway opioid receptors
(guinea pigs), 863
Coupry, I., Atlas, D., Podevin, R.-A., Uzielli,
I. and Parini, A.: Imidazoline-guani-dinium receptive site in renal proxi-
mal tubule: Asymmetric distribution,regulation by cations and interaction
with an endogenous clonidine dis-
placing substance, 293
Coward, D. M., Dixon, A. K., Urwyler, S.,
White T. G., Enz, A., Karobath, M.and Shearman, G.: Partial dopamine-agonistic and atypical neurolepticproperties of the amino-ergolinesSDZ 208-911 and SDZ 208-912, 279
Cox, R. H.: Effects of putative K� channelactivator BRL-34915 on arterial con-traction and �RB efflux, 51
Craft, R. M. and Dykstra, L. A.: Differentialcross-tolerance to opioids in squirrelmonkeys responding under a shocktitration schedule, 945
Cragoe, E. J., Jr., see Jagadeesh, G., 1184Craig, D. A. and Clarke, D. E.: Pharmaco-
logical characterization of a neuronal
receptor for 5-HT in guinea pig ileumwith properties similar to the 5-HT4
receptor, 1378
Creatine kinase, cardioprotective effects ofsodium nitrite, myocardial ischemia,reperfusion (cats), 35
Crino, P. B., Vogt, B. A., Volicer, L. and
Wiley, R. G.: Cellular localization ofserotonin 1A, lB and uptake sites incingulate cortex of the rat, 651
Criswell, H. E., see Breese, G. R., 558Cromakalim
actions on ionic currents, single smoothmuscle cells, portal vein (rats), 832
arterial contraction and Rb-86 efflux,BRL-34915 (rats), 51
excitatory noncholinergic and cholinergicneurotransmission, airways (guineapigs), 1207
renal hemodynamics and function (dogs),
1240
Cubeddu, L. X., see Faggin, B. M., 817
Cutz, E., see Adeagbo, A. S. 0., 875
1990 Index 1391
Cyclic AMPaccumulation, phosphoinositide turnover,
noradrenalin release from adrenalchromaffin cells, 1296
adenylate cyclase activity, chronicethanol exposure, PC 12 cells, 1021
adenylate cyclase coupling, beta adreno-ceptor binding, pulmonary artery vs.aorta (rats), 86
-dependent protein kinase, activation,lower esophageal sphincter relaxa-
tion (dogs), 1160formation and dopamine release, CGS
21680 effects on electrophysiology,hippocampus and striatum (rats),1134
mechanisms of vascular action, parathy-roid hormone, 840
mouse neuroblastoma x rat glioma hybridcells, muscarinic cholinergic recep-
tom, 616neurohormonal regulation of ion trans-
port, distal jejunum (pigs), 126ontogeny of cortical muscarinic receptor
subtypes (rats), 482phosphodiesterase inhibitor, nonadre-
nergic neural relaxation, airway
(guinea pigs), 396Cyclic GMP
attenuation of vascular relaxation, cyclo-sporin A (rats), 165
stimulation of production by bradykinin,B2 kinin receptors, aortic endothelialcells (porcine), 581
Cyclic GMP phosphodiesterase, morphinetolerance (rats), 104
Cyclooxygenase, modulation of renal re-
sponse, atrial natriuretic peptide, en-
dothelin (rats), 1213Cyclosporin A, vascular relaxation and
cyclic GMP responses (rats), 165Cytochrome P-450
bronciolar Clara cell necrosis, naphtha-lene, lung (mice), 428
CYP2C subfamily, tolbutamide, mephen-ytoin hydroxylation (humans), 442
inhibitors, metabolism, all-trans-retinoicacid (rats), 365
mechanism in contractile tension, ductusvenosus (lambs), 875
Dadan, J., , see Perico, N., 1213Daly, J. W., see Gusovsky, F., 466Daniase-Michel, C., Montastruc, J.-L.,
Gharib, C., Geelen, G., de Saint-Blanquat, G. and Tran, M.-A.: Effectof quinpirole, a specific dopamineDA2 receptor agonist on the sympa-thoadrenal system in dogs, 770
Dardik, B. N., see Chatelain, R. E., 117Dean, R., see Ciaranello, R. D., 1347de Costa, B. R., see France, C. P., 600Delmendo, R., see Blue, D. R., 1034Denervation, chronic, electrophysiology, ad-
renergic neurotransmission (dogs),1197
de Paulis, T., see Nerve, K. A., 1108Deray, G., Sabra, R., Herzer, W. A., Jack-
son, E. K. and Branch, R. A.: Inter-action between angiotensin II andadenosine in mediating the vasocon-
strictor response to intrarenal hyper-
tonic saline infusions in the dog, 631
Dermorphin, respiratory and locomotorstimulation (rats), 235
de Saint-Blanquat, G., see Damase-Michel,C., 770
Desimipramine, lithium and, serotonergicreceptor number, second messengerfunction in brain (rats), 826
Deth, R. C., see Jagadeesh, G., 1184Dewey, W. L., see Welch, S. P., 140Dextrorphan, blockade of voltage-depend-
ent potassium currents, phencycli-dine, thymocytes (mice), 610
Diaphragm, activation of ventral medullaryserotonin receptor subtypes, cardio-vascular activity (cats), 665
Digoxin, inhibition of electrogenic Na�-pumping, atrial tissue (humans), 60
Dihydroalprenolol, antagonist characteriza-tion, atypical beta adrenoceptors(guinea pigs), 1034
Dihydropyridine, calcium channel antago-nists, antiseizure activity (rats), 1150
Diltiazemcatamphiphilic drug uptake, calcium cbs-
placement, erythrocytes and muscu-lar tissue (humans), 333
gastric proton pump inhibition, calciumchannel antagonists (rabbits), 1102
Dimethylaminoethanol, disposition of cho-
line in kidney (rats), 154
Dimethylanatoxin, molecular effects, pe-
ripheral nicotinic acetylcholine re-
ceptor, 5072,3-Diphosphoglycerate phosphatase/syn-
thase, elevation of diphosphoglycer-ate level, red blood cells (humans),192
Discrimination, low-dose caffeine (hu-
mans), 970Discriminative stimulus, phencyclidine-like
properties, self-administration, MK-801 (monkeys), 953
Diuresis
renal hemodynamics and function, cr0-makalim effects (dogs), 1240
resistance in nephrotic syndrome, furo-
semide-A, intratubular albumin(rats), 1097
Dixon, A. K., see Coward, D. M., 279Dodge, B. B., see Bloxham, D. P., 1331Doleial, V. and Wecker, L.: Muscarinic re-
ceptor blockade increases basal ace-tylcholine release from striatal slices,739
Domurat, E. S., see Elias, A. N., 384Dooley, D. J., see Feuerstein, T. J., 778Dopamine
-agonistic and neuroleptic properties,SDZ 208-911 and SDZ 208-912 (rats),279
mesoprefrontal neurons, modulation, cen-tral benzodiazepine receptors, 989
neurotensin-induced release, substantia
nigra, nucleus caudate (rabbits), 817release in hippocampus and striatum,
CGS 21680 effects, electrophysiology(rats), 1134
sodium-dependent release, noradrenaline,
brain synaptosomes (rats), 1283Doxorubicin, blockade of increase in intra-
cellular calcium, neuroblastoma cells,
979Drack, E., see Scheurer, U., 1324Drieman, J. C., Thijssen, H. H. W., Struy-
ker-Boudier, H. A. J.: Renal selectiveN-acetyl--y-glutamyl prodrugs. II.Carrier-mediated transport and in-
tracellular conversion as determi-nants in the renal selectivity of N-acetyl--y-glutamyl sulfamethoxazole,1255
Drummer, D., see Newman, M. E., 826Drummer, 0. H., Nicolaci, J. and Sakovidis,
D.: Biiary excretion and conjugationof DI-acid angiotensin-converting
enzyme inhibitors, 1202Ductus venosus, cytochrome P-450 mecha-
nism, contractile tension (lambs),875
Duncan, G. E., see Paul, I. A., 997Duncia, J. V., see Chiu, A. T., 711Duncia, J. V., see Wong, P. C., 719, 726Dunwiddie, T. V., see Lupica, C. R., 1134DuP 753, nonpeptide angiotensin II recep-
tsr antagonists (rats), 711, 719, 726Dykstra, L. A., see Craft, R. M., 945Dynorphin A, differential release, substance
P and somatostatin, spinal cord(rats), 539
Dynorphinsanalgesia produced by E-2078 (mice),
1247nonpeptide kappa opioid receptor agonists
and, different motor actions, colon(rats), 1324
E-2078, analgesia (mice), 1247Egan, R. W, see Billah, M. M., 1090Eglen, R. M., see Blue, D. R., 1034Eicosanoids
cytochrome P-450 mechanism in con-tractile tension, ductus venosus
(lambs), 875
thromboxane A2/prostaglandin H2 recep-tsr, endothelin, aorta (rats), 915
Electrophysiologyadrenergic neurotransmission, chronic
denervation, saphenous veins (dogs),1197
effects of CGS 21680, cAMP formation,hippocampus and striatum (rats),1134
effects of metoprolol, ventricular myo-cytes (cats), 1043
Elias, A. N., Vaziri, N. D., Domurat, E. S.,Pandian, M. R., Ansari, M. A. andYazdani, M.: Atrial natriuretic pep-tide; arginine vasopressin, aldoste-rone and plasma renin activity in car-bon tetrachloride-induced cirrhosisin rats, 384
Ellinwood, E. H., see Kabas, J. S., 185Enalapril, biliary excretion and conjugation
(rats), 1202$-Endorphin, -induced inhibition, tail-flick
response, mechanisms (rats), 546Endothelial cells, aortic, cyclic GMP pro-
duction, bradykinin (porcine), 581
Endothelin-induced contractions of smooth muscle,
pinacidil antagonism, lungs (guineapigs, rats), 1318
modulation of renal response, cyclooxy-genase products, atrial natriureticpeptide (rats), 1213
thromboxane A2/prostaglandin H2 recep-tor, vasoconstrictor response, aorta(rats), 915
Endothelin-1, hemodynamic and pharma-
cological evaluation, vasodilator andvasoconstrictor effects (rats), 300
Endothelium
1392 Index Vol. 252
basal tone and agonist, oxygen sensitivity,coronary artery (pigs), 1053
binding and functional studies, musca-rinic cholinoceptors, coronary artery(porcine), 765
-dependent modulation of vasoconstric-tion, membrane depolarization, cere-bral arteries (cats), 93
-dependent relaxation
5-hydroxytryptamine-induced, coro-nary arteries (pigs), 387
pertussis toxin, pulmonary artery (rab-bits), 260
endogenous prostaglandins, angiotensinIl-induced contractions, cerebral andmesenteric arteries (dogs, monkeys),374
mechanism of vascular actions, prostacy-din, mesenteric arteries (rats), 26
Endothelium-derived relaxing factor
cardioprotective effects, sodium nitrite,myocardial ischemia (cats), 35
nitric oxide, spectrophotometric and bio-logical assays, 922
Enero, M. A., see Kazanietz, M. G., 758England, D. M., see Buckner, C. K., 77English, J., see Welch, S. P., 370enhanced capacity of PGEI receptors to
stimulate cAMP accumulation, 616Enkephalin, GABAergic modulation of mo-
tor activity, ventral pallidum (rats),
1370Enkephalinase, recombinant, prevention,
capsaicin-induced miosis in eye (rab-bits), 462
Enz, A., see Coward, D. M., 279Epidepride, sodium-dependent isomeriza-
tion, dopamine D-2 receptors, 1108Epidermal growth factor, -urogastrone, cor-
onary artery receptor systems (por-cine, bovine), 1277
Epithelia, W-secreting, inhibition of acidi-fication, prostaglandin F� (frogs),929
Epithelial cells, renal, oxytocin stimulation,phosphoinositide hydrolysis, 552
Epithelium, contractile responses to pepti-doleukotrienes, blockade by IC! 204,219 (guinea pigs), 77
Erythrocytes, uptake of catamphiphilicdrugs, calcium displacement, phos-phatidylserine monolayers (humans),333
Esophaguslongitudinal smooth muscle, bradykinin
effect (opossums), 1012lower, sphincter relaxation, cAMP-de-
pendent protein kinase (dogs), 1160Esterase, inhibition, zomepirac glucuronide
disposition, plasma protein binding(guinea pigs), 218
17$-Estradiol, uremic bleeding (rats), 344Ethanol
chronic exposure of PC 12 cells, adenylatecyclase activity, cAMP content, 1021
consumption and aging, muscarinic cho-linergic receptors, brain (rats), 869
GABAA agonists and, contractile re-
sponses, ileum longitudinal muscle
(guinea pigs), 474inhibition of zymosan-stimulated PAF
production, clonal macrophage cellline, 1028
tolerance in hippocampal neurons (rats),265
Ethanol/chloral hydrate, isobolographic
characterization, drug interactions,biological variability (mice), 208
Ethylhexanol, 02-dependent hepatotoxicity,
mitochondria, liver (rats), 1355Ethylketazocine, differential cross-toler-
ance, shock titration schedule (mon-keys), 845
Evans, S. M., see Griffiths, R. R., 970Eye, capsaicin-induced miosis, prevention,
recombinant enkephalinase (rab-bits), 462
Eylers, J. P., see Kudlacz, E. M., 42
Faggin, B. M., Zubieta, J. K., Rezvani, A.H. and Cubeddu, L. X.: Neurotensin-induced dopamine release in Vivoand in Vitro from substantia nigraand nucleus caudate, 817
Fat cells, a�pha-2 A adrenoceptor character-ization (humans), 312
Fauth, C., see Fouda, A.-K., 286Favaron, see Manev, H., 419Fedyna, J. S., see Buckner, C. K., 77Fenfluramine, D-amphetamine and, toler-
ance, food intake (baboons), 960Fenwick, J. W., see Hughes, J. R., 1175Feuerstein, G., see Paakkari, P., 235Feuerstein, T. J., Dooley, D. J. and Seeger,
W.: Inhibition of norepinephrine andacetylcholine release from humanneocortex by w-conotoxin GVIA’, 778
Filice, G. A., see Chao, C. C., 605Fincher, A. S., see Frye, G. D., 474Fiorica-Howells, E., Gambale, F., Horn, R.,
Osses, L. and Spector, S.: Phencycli-
dine blocks voltage-dependent potas-sium currents in murine thymocytes,610
Fischman, M. W., see Kelly, T. H., 934Fisher, S. K., see Thompson, A. K., 744Flavahan, N. A., see Komori, K., 1197Flawia, M. M., see Rubinstein, M., 810Floch, A., see Tahraoui, L., 1221Flunarizine, catamphiphilic drug uptake,
calcium displacment, erythrocytesand muscular tissue (humans), 333
Foegh, M. L., see Rego, A., 165Foltin, R. W., see Kelly, T. H., 934Foltin, R. W.: Differential development of
tolerance to the effects of d-amphet-amine and fenfluramine on food in-
take in baboons, 960Formalin, transmission of nociceptive infor-
mation, substance P and somato-statin, spinal cord (mice), 1261
F#{246}rstermann, U., see Hohlfeld, J., 260Fouda, A.-K., Fauth, C. and Roch-Ramel,
F.: Transport of organic cations bykidney epithelial cell line LLC-PK,,286
Foy, B., see Hrdina, P. D., 410France, C. P., de Costa, B. R., Jacobson, A.
E., Rice, K. C. and Woods, J. H.:Apparent affinity of opioid antago-
nists in morphine-treated rehesusmonkeys discriminating between sa-
line and naltrexone, 600Frye, G. D., Fincher, A. S., Lorenzetti, M.,
Trzeciakowski, J. and Griffith, W.H.: Comparison of contractile re-sponses of the guinea pig ileum lon-gitudial muscle to ethanol and GA-BAA agonists, 474
Fujimoto, S. and Matsuda, T.: Effects of
pimobendan, a cardiotonic and vaso-dilating agent with phosphodiester-ase inhibiting properties, on isolatedarteries and veins of rats, 1304
Fujiwara, M., see Okada, M., 1283�3-Funaltrexamine, mu and kappa agonist
properties, spinal analgesia (rats),1006
Furosemide-A, mechanism for diuretic re-
sistance, intratubular albumin, ne-phrotic syndrome (rats), 1097
Furukawa, 0., see Takeuchi, K., 1228Furuya, Y., see Nakazawa, T., 1247
Gabanelli, M., see Perico, N., 1213Gabexate, camostat and, water and bicar-
bonate secretion, pancreas (dogs),
320Gainey Matta, S., McAllen, K. M. and
Sharp, B. M.: Role of the fourth cer-ebroventricle in mediating rat plasma
ACTH responses to intravenous nic-otine, 623
Galitzky, J., Larrouy, D., Berlan, M. andLafontan, M.: New tools for humanfat cell Alpha-2A adrenoceptor char-acterization. Identification on mem-branes and on intact cells using the
new antagonist [3H]RX821002, 312Gambale, F., see Fiorica-Howells, E., 610Gan, B. S. and Hollenberg, M. D.: Distinct
coronary artery receptor systems forepidermal growth factor-urogastrone,1277
Ganapathy, V., see Miyamoto, Y., 98Gangliosides, glutatmate-induced neuronal
death, cerebellar granule cells (rats),
419Garattini, S., see Vigan#{224},G., 344Garg, L. C., Wozniak, M. and Phillips, M.
I.: Stimulation of phosphoinositidehydrolysis by oxytocin in renal epi-
thelial cells, 552Geelen, G., see Dainase-Michel, C., 770Gennings, C., Carter, W. H., Jr., Campbell,
E. D., Staniswalis, J. G., Martin, T.J., Martin, B. R., and White, K. L.,Jr.: Isobolographic characterizationof drug interactions incorporating bi-
ological variability, 208Gershanik, 0., see Rubinstein, M., 810Gharib, C., see Damase-Michel, C., 770Gilchrest, H., see Billah, M. M., 1090Gill, K. K. and Kroeger, E. A.: Effects of
indomethacin on neural and my-
ogenic components in equine airway
smooth muscle, 358Gillis, R. A., see Jam, R. K., 147Giuliani, S., Lippe, I. Th., Maggi, C. A. and
Meli, A.: Dual effects of cholecysto-kinin-octapeptide on duodenal motil-ity ofurethane-anestheized rats, 1312
Glibenclamide, renal hemodynamics andfunction, cromakalim effects (dogs),1240
N-Glucuronides, norgallopamil and norver-apamil, 593
Glutamate-induced neuronal death, cerebellar gran-
ule cells (rats), 419NDMA receptor system, evoked GABA
release, striatal neurons (mice), 380
Glutathione
bronchiolar Clara cell necrosis, naphtha-
lene, lung (mice), 428
1990 Index 1393
inhibition ofacid formation, AG-1749, pa-
rietal cells (dogs), 1289Glycine, antagonists, NMDA-induced con-
vulsions, NMDA antagonists (mice),
349Goldberg, S. R., see Schindler, C. W., 8Goldberg, S. R., see Tella, S. R., 491Golfarb, J., see Christ, G. J., 500Gonzalez, F. J., see Relling, M. V., 442Goon, D. and Klaassen, C. D.: Dose-depend-
ent intestinal glucuronidation andsulfation of acetaminophen in the rat
in Situ, 201Goossens, J., see van Wauwe, J. P., 365Goyal, R. K., see Saha, J. K., 1012G-protein
-linked serotonin receptors in kidney, 5-HT1b receptors in brain (mice), 1347
pertussis toxin effect, interaction, azepex-ole and halothane (guinea pigs), 1156
Greenwald, J., see Cicero, T. J., 456Griffith, W. H., see Frye, G. D., 474Griffiths, R. R., Evans, S. M., Heishman, S.
J., Preston, K. L., Sannerud, C. A.,Wolf, B. and Woodson, P. P.: Low-dose caffeine discrimination in hu-
mans, 970Grous, M., see Barnette, M. S., 1160Gruber, S. A., Cipolle, R. J., Tzardis, P.,
Skjei, K., Jossart, G., Abed, J. F.,Canafax, D. M., Burke, B. A., Mates,
A. J. and Hrushesky, W. J. M.: Phar-macodynamics of local heparin infu-sion in a canine renal allograft model,733
Guarino, J. J., see Boisse, N. R., 1125Guidotti, A., see Manev, H., 419Gulati, A., see Bhargava, H. N., 901Gusovsky, F., Bitran, J. A., Yasumoto, T.
and Daly, J. W.: Mechanism of mai-totoxin-stimulated phosphoinositide
breakdown in HL-60 cells, 466Gust, S. W., see Hughes, J. R., 1175
H-7, effect on stress, crossbridge phosphor-ylation, inositol phosphate produc-
tion in arteries (rabbits), 253Haloperidol, SCH 23390 and, dopaminergic
and serotonergic mechanisms, brain(rats), 845
Halothane, azepexole and, pertussis toxineffect (guinea pigs), 1156
Halter, F., see Scheurer, U., 1324Hamosh, P., see Jam, R. K., 147Harada, Y., see Yamada, S., 327Harbon, S., see Leiber, D., 800Harder, D. R., see Kauser, K., 93Hartz, R. S., see Rasmussen, H. H., 60Hayashi, K., Matsumura, Y., Yoshida, Y.,
Ohyama, T., Hisaki, K., Suzuki, Y.and Morimoto, S.: Effects of BRL34915 (cromakalim) on renal hemo-
dynamics and function in anesthe-
tized dogs, 1240Hayes, B. A., see Beardsley, P. M., 953Heart
atrial tissue, electrogenic Na�-pumping
inhibition, digoxin (humans), 60
cocaine-mediated impairment (dogs), 185
potentiation of cardiac effects, cocaine,neurally released norepinephrine
(cats), 147prazosin-sensitive component, inotropic
response to norepinephrine (rabbits),853
rate perfusion pressure, substance P(guinea pigs), 179
role of membrane lipid order, tetrahydro-cannabinol, adenylate cyclase acti-vation (rats), 1075
Heat, noxious, differential release, sub-stance P and somatostatin (rats), 539
Heishman, S. J., see Griffiths, R. R., 970Hemodynamics
evaluation of endothelin-1 (rats), 300renin inhibition induced by A-64662, ex-
cretory responses (monkeys), 449Henningsen, R. A., see Nerve, K. A., 1108Heparin, local infusion, pharmacodynamics,
renal allograft model (dogs), 733Hepatocytes, altered hepatobiliary disposi-
tion, acetaminophen metabolites,phenobarbital pretreatment (rats),657
Hepatotoxicity
acetaminophen, methylxanthines, induc-
tion states (rats), 11202-dependent, ethylhexanol, mitochon-
dna (rats), 1355
Hepner, A., see Hrdina, P. D., 410Herczeg, T., see Yu, K. T., 192Herman, J. R. and Bass, P.: Pharmacologic
characterization of the changes in
cholinergic sensitivity of rat jejunalcircular muscle after myentericplexus ablation, 135
Hernandez, J. S., Van Loon, J. A., Otter-ness, D. M. and Weinshilboum, R.
M.: Mouse thiopurine methyltrans-ferase pharmacogenetics: Correlationof immunoreactive protein and en-
zymatic activity, 568
Herzer, W. A., see Deray, G., 631Heyman, J. S., see Jiang, Q., 1006Hieble, J. P., see Willette, R. N., 706Hietala, J., see Lappalainen, J., 845Hillard, C. J., Pounds, J. J., Boyer, D. R.
and Bloom, A. S.: Studies of the roleof membrane lipid order in the effects
of $�-tetrahydrocannabinol on eden-ylate cyclase activation in heart, 1075
HippocampusCA3 pyramidal cells, mu opioid receptor
activation, inhibitory postsynapticpotentials (rats, guinea pigs), 1361
CGS 21680 effects on electrophysiology,cAMP formation, dopamine release(rats), 1134
ethanol tolerance in neurons (rats), 265glycine-evoked neurotransmitter release
(rats), 574Hisaki, K., see Hayashi, K., 1240Histamine
block of increase in intracellular calcium,doxorubicin, neuroblastoma cells,
979dual antagonist, SCH 37370 (guinea pigs),
1090tachykinin-induced anion secretion, dis-
tal colon (guinea pigs), 1HL-60 cells, maitotoxin-stimulated phos-
phoinositide breakdown, mechanism,466
Ho, I. K., see Burton, C. K., 104Hoffman, B. B., see Thomas, J. M., 616Hoffman, G. W., Jr., see Kabas, J. S., 185Hohlfeld, J., Liebau, S. and F#{246}rstermann,
U.: Pertussis toxin inhibits contrac-tions but not endothelium-dependentrelaxations of rabbit pulmonary ar-
tery in response to acetylochline andother agonists, 260
Hoke, G. D., Cheng, H.-Y., Mirabelli, C. K.and Rush, G. F.: Mechanism of inhi-bition of rat liver mitochondrial res-
piration by oxmetidine, an H2-recep-tor antagonist, 908
Hollenberg, M. D., see Gan, B. S., 1277Holtman, J. R., Jr., see King, K. A., 665Hong, J.-S., see Paul, I. A., 997Hoover, D. B.: Effects of substance P on
rate and perfusion pressure in theisolated guinea pig heart, 179
Hori, R., see Tomita, Y., 859Horiuchi, A., Iwatsuki, K., Yonekura, H.,
Ran, L-M. and Chiba, S.: Gabexateand camostat, synthetic proteinaseinhibitors, as direct inducing factorsof water and bicarbonate secretion inthe isolated and blood-perfused dogpancreas, 320
Horn, R., see Fiorica-Howells, E., 610Hoskins, B., see Burton, C. K., 104Hoyer, D., see Schoeffter, P., 387Hrdina, P. D., Foy, B., Hepner, A. and Sum-
mers, R. J.: Antidepressant bindingsites in brain: Autoradiographic com-parison of [3Hjparoxetine and 13H1imipramine localization and relation-ship to serotonin transporter, 410
Hruby, V. J., see Spencer, R. L., 696Hrushesky, W. J. M., see Gruber, S. A., 733Hsu, C.-Y., see Tune, B. M., 65Hughes, H., see Shappell, S. B., 531Hughes, J. R., Gust, S. W., Keenan, R. M.
and Fenwick, J. W.: Effect of dose onnicotine’s reinforcing, withdrawal-
suppression and self-reported effects,1175
Hulihan-Giblin, B. A., Lumpkin, M. D. andKeller, K. J.: Effects of chronic ad-ministration of nicotine on prolactinrelease in the rat: Inactivation of pro-lactin response by repeated injectionsof nicotine, 21
Hulihan-Giblin, B. A., Lumpkin, M D. and
Kellar, K. J.: Acute effects of nicotineon prolactin release in the rat: Ago-nist and antagonist effects of a singleinjection of nicotine, 15
Hunter, J. B., see Scheufler, E., 333Huxtable, R. J., see Shubat, P. J., 705-Hydroxytryptamine2, receptor character-
ization, medial prefrontal cortex
(rats), 1715-Hydroxytryptamine, see also Serotonin
-induced endothelium-dependent relaxa-tion, coronary arteries (pigs), 387
receptors, see ReceptorsHyman, A., see Le Monnier de Gouville, A.
C., 300Hypertension
antihypertensive effects of CGS 19281A(rats), 117
genetic, phorbol-12,13-dibutyrate, vaso-
constriction (rats), 526nonpeptide angiotensin H receptor antag-
onists, DuP 753 (rats), 711, 719, 726
Ichinose, M. and Barnes, P. J.: A potassiumchannel activator modulates both ex-citatory noncholinergic and cholin-ergic neurotransmission in guinea pig
airways, 1207IC! 204,219, contractile responses to pepti-
1394 Index Vol. 252
doleukotrienes, epithelium (guinea
pigs), 77Ileum
atypical beta adrenoceptors, antagonistcharacterization (guinea pigs), 1034
comparison of contractile responses,ethanol and GABAA agonists, longi-tudinal muscle (guinea pigs), 474
contractile response te bombesin, longi-
tudinal muscle (guinea pigs), 339
pertussis toxin effect, interaction, azepex-ole and halothane (guinea pigs), 1156
pharmacological characterization, neu-ronal receptor, serotonin (guineapigs), 1378
Imidazoline, -guanidinium receptive site,renal proximal tubule (rabbits), 293
Imipramineantidepressant binding sites in brain
(rats), 410neural adaptation, forced swim test (rats),
997Indole, antagonism of -y-aminobutyric acidA
receptor, amino--y-carbolines (mice),1269
Indolealkylamines, melatonin analogs,
quantitative structure-activity rela-tionships, 370
Indomethacin, effects on neural and my-ogenic components, airway smoothmuscle (horses), 358
Inoki, R., see Ohkubo, T., 1261Inositol phosphate
agonist-induced muscarinic receptor loss,phosphoinositide turnover, neuro-blastoma (humans), 744
desimipramine and lithium, serotonergicreceptor number, second messengerfunction in brain (rats), 826
increased generation, muscarinic receptorsubtypes, myometrium (guinea pigs),800
production in arteries, effect of H-7,crossbridge phosphorylation (rab-bits), 253
Inositol polyphosphates, formation in air-way smooth muscle, muscarinic re-ceptor stimulation, 786
Intestinebrush-border membrane, transport mech-
anisms, bestatin (rabbits), 859duodenal motility, cholecystokinin-octa-
peptide, urethane (rats), 1312glucuronidation and sulfation, acetami-
nophen (rats), 201Inui, K.-!., see Tomita, Y., 859Ion channel
acetylcholine receptor, activation and
blockade, anatoxin-a (frogs), 517molecular effects of dimethylanatoxin,
peripheral nicotinic acetylcholine re-ceptor, 507
Ionic current, cromakalim actions, singlesmooth muscle cells, portal vein(rats), 832
Ionsneurohormonal regulation of transport,
distal jejunum (pigs), 126transport in jejunum, nerve stimulation,
Veratrum alkaloids (mice), 636Iorio, L. C., see Breese, G. R., 558Ischemia, myocardial, cardioprotective ef-
fects, sodium nitrite (cats), 35Isobologram, drug interactions, biological
variability (mice), 208
Isoproterenol, chronic administration, al-
tered beta adrenoceptor-G,-coupling,lung (guinea pigs), 1341
Iwatsuki, K., see Horiuchi, A., 320
Jackson, E. K., see Deray, G., 631Jacobson, A. E., see France, C. P., 600Jagadeesh, G., Cragoe, E. J., Jr. and Deth,
R. C.: Modulation of bovine aorticalpha-2 receptors by Na�,Gpp(NH)p, amiloride and ethyliso-propylamiloride: Evidence for recep-tor/G-protein precoupling, 1184
Jam, M. K., see Jam, R. K., 147Jam, R. K., Jam, M. K., Bachenheimer, L.
C., Visner, M. S., Hamosh, P., Tracy,C. M. and Gillis, R. A.: Factors deter-mining whether cocaine will poten-tiate the cardiac effects of neurallyreleased norepinephrine, 147
Jan, C.-R., see Bigornia, L., 586Janowsky, A., see Nerve, K. A., 1108Jejunum
circular muscle, cholinergic sensitivity,
myenteric plexus ablation (rats), 135distal, neurohormonal regulation, ion
transport (pigs), 126ion transport, nerve stimulation, Vera-
trum alkaloids (mice), 636
Jiang, L. H., see Ashby, C. R., Jr., 171Jiang, Q., Heyman, J. S., Sheldon, R. J.,
Koslo, R. J. and Porreca, F.: Mu an-tagonist and kappa agonist propertiesof fl-funaltrexamine in Long lasting
spine.! ana�gesla in mice, 1006Johns, R. A., see Tracey, W. R., 922Johnson, A. L., see Chiu, A. T., 711Johnson, A. L., see Wong, P. C., 719, 726Johnson, G., III, Tsao, P. S., Mulloy, D. and
Lefer, A. M.: Cardioprotective effects
of acidified sodium nitrite in myocar-
dial ischemia with reperfusion, 35Johnson, R. E., see Vaupel, D. B., 225Jones, J. A., see Brouwer, K. L. R., 657Jones, J. A., see Plevin, R., 1296Jossart, G., see Gruber, S. A., 733
Kabas, J. S., Blanchard, S. M., Matsuyama,Y., Long, J. D., Hoffman, G. W., Jr.,Ellinwood, E. H., Smith, P. K. andStrauss, H. C.: Cocaine-mediated im-pairment of cardiac conduction in thedog A potential mechanism for sud-
den death after cocaine, 185Kadam, J. R. C., see Verburg, K. M., 449Kado-Fong, H., see Malfroy, B., 462Kainate, phencyclidine-like behavioral ef-
fects, NMDA-induced convulsions,NMDA and glycine antagonists(mice), 349
Kajioka, S., see Okabe, K., 832Kalhorn, T. F., Lee, C. A., Slattery, J. T.
and Nelson, S. D.: Effect of meth-ylxanthines on acetaminophen he-patoxicity in various inductionstates, 112
Kalivas, P. W., see Austin, M. C., 1370Kanai, Y., Wada, 0. and Manabe, S.: An-
tagonism of -y-aminobutyric acidA re-ceptor-mediated responses by amino-y-carbolines, 1269
Kanekal, S., Plopper, C., Morin, D. andBuckpitt, A.: Metabolic activationand bronchiolar clara cell necrosis
from naphtahalene in the isolatedperfused mouse lung, 428
Kaneko, T., see Nakazawa, T, 1247Kanno, S., see Takahashi, H., 272Kaplan,D.S.,seeNandi,J., 1102Karakiulakis, G., see Maragoudakis, M. E.,
753Karlssson, J.-A., Lanner, A.-S. and Persson,
C. G. A.: Airway opioid receptors me-diate inhibition of cough and reflexbronchoconstriction in guinea pigs,863
Karobath, M., see Coward, D. M, 279Kasiewski, C. J., see Bilder, G. E., 526Kasser, R. J., see Ashby, C. R., Jr., 171Katsura, T., see Tomita Y., 859Katz, J. L., see Schindler, C. W., 8Kau, D., see Lindatrom T. D., 1117Kauffman, F. C., see Keller, B. J., 1355Kauser, K., Rubanyi, G. M. and Harder, D.
R.: Endothelium-dependent modula-tion of endothelin-induced vasocon-striction and membrane depolarize-tion in cat cerebral arteries, 93
Kawai, Y. and Ohhashi, T.: Age-relatedchanges in relaxant response of vas-cular smooth muscles to atrial natri-uretic peptide, 1234
Kawasaki, H., Nuki, C., Saito, A. and Tak-asaki, K.: Role of calcitonin gene-related peptide-containing nerves in
the vascular adrenergic neurotrans-mission, 403
Kazanietz, M. G. and Enero, M. A.: Desen-sitization ofthe Beta-2 adrenoceptor-mediated vasodilation in rat aorta
after prolonged treatment with theBeta-2 adrenoceptor agonist clenbu-terol, 758
Keenan, R. M., see Hughes, J. R., 1175Keith, R. A., see Mangano, T. J., 574Kellar, K. J., see Hulihan-Giblin, B. A., 15,
21
Keller, B. J., Yamanaka, H., Liang, D.,Kauffman, F. C. and Thurman, R.G.: Oxygen-dependent hepatotoxicitydue to ethylhexanol in the perfusedrat liver: Mitochondria as a site ofaction, 1355
Kelly, T. H., Foltin, R. W., Rose, A. J.,Fischman, M. W. and Brady, J. V.:
Smoked marijuana effects on tobaccocigarette smoking behavior, 934
Kessler, R. M., see Nerve, K. A., 1108Khanna, J. M., see Reynolds, J. N., 265Kidney
acute renal failure, peptidases, brush-bor-der membrane vesicles (rats), 98
disposition of choline, dimethylaminoe-
thanol (rats), 154epithelial cells
organic cation transport, 286oxytocin stimulation, phosphoinositide
hydrolysis, 552
G-protein-linked serotonin receptors, 5-HTIb receptors in brain (mice), 1347
hemodynamics and function, cromakalimeffects (dogs), 1240
mitochondrial toxicity, cephalosporins(rabbits), 65
modulation of renal response to endothe-lin, cycbooxygenase products, atrialnatriuretic peptide (rats), 1213
phenobarbital pretreatment, altered hep-
1990 Index 1395
atobiliary disposition, acetamino-phen metabolites (rats), 657
proximal tubular transport, mechanism,angiotensin II action (rats), 689
proximal tubule, imidazoline-guanidi-nium receptive site (rabbits), 293
renal allograft model, pharmacody-namics, local heparin infusion (dogs),733
renal selective N-acetyl--y-glutamyl pro-drug, 1255
renin inhibition by A-64662, hemody-namic and excretory responses (mon-keys), 449
tachyphylaxis to vasoconstrictor effect,arachidonic acid (rats), 241
urate and p-aminohippurate transport,brush border membrane (pigs), 792
Killam, A. L., Nikam, S. S., Lambert, G. M.,Martin, A. R. and Nelson, D. L.:Comparison of two different arterialtissues suggests possible 5-hydroxytryptamine2 receptor hetero-geneity, 1083
Kimura, R., see Yamada, S., 327King, K. A. and Holtman, J. R., Jr.: Char-
acterization of the effects of activa-tion of ventral medullary serotoninreceptor subtypes of cardiovascularactivity and respiratory motor out-flow to the diaphragm and larynx,665
King, R. L., see Nandi, J., 1102Kinins, cyclic GMP production, bradykinin,
aortic endothelial cells (porcine), 581Kinzie, J. M., see Nerve, K. A., 1108Kirchner, K. A., Voelker, J. R. and Brater,
D. C.: Intratubular albumin bluntsthe response to furosemide-A mech-anism for dieuretic resistance in thenephrotic syndrome, 1097
Kitamura, K., see Okabe, K., 832Klaassen, C. D., see Goon, D., 201Kleinert, H. D., see Verburg, K. M., 449Kook, W. and Colpaert, F. C.: Selective
blockade of N-methyl-D-aspartate(NMDA)-induced convulsions byNMDA antagonists and putative gly-cine antagonists: Relationship withphencyclidine-like behavioral effects,349
Kofuji, P., Aracava, Y., Swanson, K. L.,Aronstam, R. S., Rapoport, H. andAlbuquerque, E. X.: Activation andblockade of the acetylcholine recep-tor-ion channel by the agonists (+)-anatoxin-a, the N-methyl derivativeand the enantiomer, 517
Komori, K., Flavahan, N. A., Miller, V. M.and Vanhoutte, P. M.: Electrophysi-ological analysis of adrenergic neu-rotransmission and its modulation bychronic denervation in canine sa-phenous veins, 1197
Koslo, R. J., see Jiang, Q., 1006Koulu, M., see Lappalainen, J., 845Krell, R. D., see Buckner, C. K., 77Kreutner, W., see Billah, M. M., 1090Kroeger, E. A., see Gill, K. K., 358Kudlacz, E. M., Navarro, H. A., Eylers, J.
P. and Slotkin, T. A.: Prenatal ex-posure to propranolol via continuousmaternal infusion: Effects on phys-iological and biochemical processes
mediated by Beta adrenergic recep-
tom in fetal and neonatal rat lung, 42Kuhn, C., see Paul, I. A., 997Kuo, J. S., see Yang, M. C. M., 840Kuriyama, H., see Okabe, K., 832Kuwahara, A. and Cooke, H. J.: Tachykinin-
induced anion secretion in guinea pigdistal colon: Role of neural and in-flammatory mediators, 1
Lafontan, M., see Galitzky, J., 312Lambert, G. M., see Killam, A. L., 1083Lanner, A.-S., see Karlsson, J.-A., 863Lappalainen, J., Hietala, J., Koulu, M., Sep-
p#{228}i#{228},T., Sj#{246}holm,B. and Syv#{228}lahti,E.: Chronic treatment with SCH23390 and haloperidol: Effects on do-paminergic and serotonergic mecha-nisms in rat brain, 845
Larrouy, D., see Galitzky, J., 312Larynx, activation of ventral medullary se-
rotonin receptor subtypes, cardiovas-cular activity (cats), 665
Lee,C.A.,seeKalhorn,T.F., 112Lee, W., Nicklaus, K. L., Manning, D. R.
and Wolfe, B. B.: Ontogeny of corti-cal muscarinic receptor subtypes andmuscarinic receptor-mediated re-sponses in rat, 482
Lees, J. G., see Adeagbo, A. S. 0., 875Lefer, A. M., see Johnson, G., III, 35Legato, M. J., see Viamonte, V. M., 886Leiber, D., Marc, S. and Harbon, S.: Phar-
macological evidence for distinctmuscarinic receptor subtypes coupledto the inhibition of adenylate cyclaseand to the increased generation ofinositol phosphates in the guinea pigmyometrium, 800
Le Monnier de Gouville, A. C., Mondot, S.,Lippton, H., Hyman, A. and Cavero,I.: Hemodynamic and pharmacologi-cal evaluation of the vasodilator andvasoconstrictor effects of endothelin-1 in rats, 300
Lerer, B., see Newman, M. E., 826Leukotriene B4, lipoxygenase inhibitors,
neutrophil function (humans), 531Leukotrienes, indomethacin effects on
neural and myogenic components,airway smooth muscle (horses), 358
Levine, R. A., see Nandi, J., 1102Lewis, D. F. V., Arendt, J. and English, J.:
Quantitative structure-activity rela-tionships within a series of melatoninanalogs and related mdolealkylam-ines, 370
Lewis, E. J., see Bloxham, D. P., 1331Liang, D., see Keller, B. J., 1355Lidocaine, catamphiphilic drug uptake, cal-
cium displacement, erythrocytes andmuscular tissue (humans), 333
Liebach, F. H., see Miyamoto, Y., 98Liebau, S., see Hohlfeld, J., 260Liggitt, D., see Maifroy, B., 462Linden, J., see Tracey, W. R., 922Lindstrom, T. D., Althaus, W. A., Ruterbor-
ies, K. J. and Kau, D.: Phamacoki-netics and disposition of the KS1/4monoclonal antibody-desacetylvin-blastine hydrazide conjugateLY203725 in rats and monkeys, 1117
Lipids, membrane order, tetrahydrocanna-binol, adenylate cyclase activation inheart (rats), 1075
Lipolysis, characterization of aipha-2 Aadrenoceptors, fat cells (humans),312
Lipoxygenase, inhibitors, neutrophil func-tion (humans), 531
Lippe, I. Th., see Giuliani, S., 1312Lippton, H., see Le Monnier de Gouville, A.
C., 300Lisinopril, biliary excretion and conjugation
(rats), 1202Lithium
desimipramine and, serotonergic receptornumber, second messenger functionin brain (rats), 826
renal hemodynamics and function, cro-makalim effects (dogs), 1240
Liu-Chen, L.-Y., see Tiseo, P. J., 539Liver
altered hepatobiliary disposition, aceta-minophen metabolites, phenobarbi-tal pretreatment (rats), 657
biliary excretion and conjugation, diacidangiotensin-converting enzyme in-hibitors (rats), 1202
intestinal glucuronidation and sulfation,acetaminophen (rats), 201
mitochondrial respiration, inhibition byoxmetidine (rats), 908
02-dependent hepatotoxicity, ethyihex-anol, mitochondria (rats), 1355
Liver microsomes, covalent binding of phen-ytoin to protein, metabolism modu-lation, thiols (mice), 895
Locomotion, NMDA-induced convulsions,NMDA and glycine antagonists(mice), 349
Lohr, J. and Acara, M.: Effect of dimethy-laminoethanol, an inhibitor of be-tame production, on the dispositionof choline in the rat kidney, 154
Long, J. D., see Kabas, J. S., 185Lorenzetti, M., see Frye, G. D., 474Lumpkin, M. D., see Hulihan-Giblin, B. A.,
15, 21Lung
bronchiolar Clara cell necrosis, naphtha-lene (mice), 428
chronic isoproterenol administration,beta adrenoceptor-G1-coupling(guinea pigs), 1341
fetal and neonatal, prenatal exposure,propanolol (rats), 42
peripheral type benzodiazepine receptors(guinea pigs), 880
smooth muscle, endothelin-induced con-tractions, pinacidil antagonism(guinea pigs, rats), 1318
Lupica, C. R., Cass, W. A., Zahniser, N. Rand Dunwiddie, T. V.: Effects of theselective adenosine A2 receptor ago-nist CGS 21680 on in vitro electro-physiology, cyclic AMP formationand dopamine release in the rat hip-pocampus and striatum, 4, 113
LY203725, KS1/4 monoclonal antibody-de-sacetyl-vinbiastine hydrazide conju-gate, pharmacokinetics, disposition(rats, monkeys), 1117
Lyon, R. A., see Bigornia, L., 586
Maayani, S., see Christ, G. J., 500Mac-i, lipoxygenase inhibitors, neutrophil
function (humans), 531Macrophages, zymosan-stimulated PAF
1396 Index Vol. 252
production, inhibition by ethanol,1028
Maggi,C.A.,seeGiuliani,S., 1312Magnesium, depression of segmental poly-
synaptic reflex, phencyclidine (rats),246
Maitotoxin, -stimulated phosphoinositidebreakdown, mechanism, HL-60 cells,466
Mak, J. C. W. and Barnes P. J.: Peripheraltype benzoidazepine receptors in hu-man and guinea pig lung: Character-ization and autoradiographic map-ping, 880
Maki, Y., see Nagaya, H., 1289Malarchik, M. E., see Sheldon, R. J., 636Malfroy, B., Liggitt, D., McCabe, J., Baugh-
man, R., Kado-Fong, H., Mulholland,K., Bridenbaugh, R. and Anderson,J.: Administration of recombinantenkephalinase (neutral endopepti-dase) prevents capsaicm-inducedmiosis in the rabbit eye in Vivo, 462
Malik, K. U., see Adeagbo, A. S. 0., 26Manabe, S., see Kanai, Y., 1269Manev, H., Favaron, M., Vicini, S., Gui-
dotti, A. and Costa, E.: Glutamate-induced neuronal death in primarycultures of cerebellar granule cells:protection by synthetic derivatives ofendogenous sphingolipids, 419
Mangano, T. J., Patel, J., Salama, A. I. andKeith, R. A.: Glycine-evoked neuro-transmitter release from rat hippo-campal brain slices: Evidence for theinvolvement of glut.aminergic trans-mission, 574
Manniello, M. J., see Chatelain, R. E., 117Manning, D. R., see Lee, W., 482Maragoudakis, M. E., Missirlis, E., Sarmon-
ika, M., Panoutsacopoulou, M. andKarakiulakis, G.: Basement mem-brane biosynthesis as a target to tu-mor therapy, 753
Marc, S., see Leiber, D., 800Marijuana
effects on tobacco cigarette smoking be-havior (humans), 934
role of membrane lipid order, adenylatecyclase activation, heart (rats), 1075
Marriott, D. B., see Plevin, R., 1296Martin, A. R., see Killam, A. L., 1083Martin, B. R., see Gennings, C., 208Martin, T. J., see Gennings, C., 208Martinez, F., see Werner, D., 792Matas, A. J., see Gruber, S. A., 733Matsuda, T., see Fujimoto, S., 1304Matsumura, Y., see Hayashi, K., 1240Matsuyama, Y., see Kabas, J. S., 185McAllen, K. M., see Gainey Matta, 5., 623McCabe, J., see Maifroy, B., 462McCall, D. E., see Chiu, A. T., 711McDonagh, A. F., see Smith, P. C., 218McDonough, K. H., see Barker, L. A., 675McGiff, J. C., see Quilley, J., 241McQuade, R. D., see Breese, G. R., 558Mecamylamine, isobolographic character-
ization, drug interactions, biologicalvariability (mice), 208
Mecanylamine, role of fourth cerebroventri-cle, plasma ACTH responses, nic-otine (rats), 623
Meisheri, K. D., Sage, G. P.,!! and Cipkus-Dubray, L. A.: Factors affecting rab-bit mesenteric artery smooth muscle
sensitivity to calcium antagonists,
1167
Melatonin, analogs and related indolealky-
lamines, quantitative structure-ac-tivity relationships, 370
Meli, A., see Giuliani, S., 1312Membrane, lipid order, tetrahydrocannabi-
nol, adenylate cyclase activation inheart (rats), 1075
Mephenytoin, hydroxylation, tolbutamide,cytochrome P450s (humans), 442
Methadone, differential cross-tolerance,shock titration schedule (monkeys),845
N-Methyl-D-aspartatedepression of segmental polysynaptic re-
flex, phencyclidine (rats), 246-induced convulsions, NMDA antago-
nists, glycine antagonists (mice), 349
Methylxanthines, acetaminophen hepato-toxicity, different induction states(rats), 112
Metoprolol, electrophysiological effects,ventricular myocytes (cats), 1043
Meyer, U. A., see RaIling, M. V., 442Michel, A. D., see Blue, D. R., 1034Midazolam, tolerance and physical depend-
ence (rats), 1125Miller, V. M., see Komori, K., 1197Mine, K., see Okada, M., 1283Miosis, capsaicin-induced, prevention, re-
combinant enkephalinase (rabbits),
462
Mirabelli, C. K., see Hoke, G. D., 908Missirlis, E., see Maragoudakis, M. E., 753Mitchell, J. R., see Shappell, S. B., 531Mitochondria
02-dependent hepatotoxicity, ethylhex-anol (rats), 1355
renal toxicity of cephalosporins (rabbits),65
respiration inhibition by oxmetidine, liver
(rats), 908Miyamoto, Y., Ganapathy, V. and Leibach,
F. H.: Peptidases and peptide trans-
port in renal brush-border membranevesicles from rats with acute renal
failure, 98
MK-801glycine-evoked neurotransmitter release,
hippocampus (rats), 574self-administration, drug-reinforcement
history, discriminative stimulusproperties (monkeys), 953
Mok, L. L. S., see Reynolds, E. E., 915
Monbaliu, J., see van Wauwe, J. P., 365Mondot, S., see Le Monnier de Gouville, A.
C., 300Monoclonal antibodies, desacetyl-vinblas-
tine hydrazine conjugate LY203725,pharmacokinetics, disposition (rats,monkeys), 1117
Monocrotaline, Na�/K�-adenosine triphos-phatase activity, pulmonary arteries(rats), 70
Montastruc, J.-L., see Damase-Michel, C.,770
Morimoto, S., see Hayashi, K., 1240Morin, D., see Plopper, C., 428Moron, M. A., Stevens, C. W. and Yaksh,
T. L.: Antiseizure activity of dihydro-pyridine calcium channel antagonistsin the conscious rat, 1150
Morphineaffinity of opioid antagonists, saline and
naltrexone discrimination (mon-keys), 600
blockade of voltage-dependent potassiumcurrents, phencyclidine, thymocytes
(mice), 610differential cross-tolerance, shock titra-
tion schedule (monkeys), 845
-induced inhibition, tail-flick response,mechanisms (rats), 546
lethality, Toxoplasma gondii infection(mice), 605
salmon calcitonin and, parathyroid hor-
mone peptide fragments (mice), 140tolerance, cyclic GMP phosphodiesterase
(rats), 104
withdrawal, dopamine D1 receptors, brainand spinal cord (rats), 901
Mucosa, gastric alkaline secretion, influence
of stress (rats), 1228
Mueller, R. A., see Breese, G. R., 558Mueller, R. A., see Paul, I. A., 997Mulholland, K., see Malfroy, B., 462Mulloy, D., see Johnson, G., I!!, 35
Muntz, K. H., see Shaul, P. W., 86Muschietti, J. P., see Rubinstein, M., 810
Musclelongitudinal
contractile responses, ethanol and GA-
BAA agonists (guinea pigs), 474
contractile response to bombesin, ileum
(guinea pigs), 339nonpeptide angiotensin II receptor antag-
onists, DuP 753 (rats), 711, 719, 726
uptake of catamphiphilic drugs, calciumdisplacement, phosphatidylserine
monolayers (humans), 333Muscle, smooth
airway
indomethacin effects, neural and my-
ogenic components (horses), 358
inositol polyphosphate formation, mus-
carinic receptor stimulation, 786carotid medial, phorbol ester-induced
stress, myosin light chain phosphor-
ylation (swine), 1068coronary artery, endothelium effects,
basal tone and agonist (pigs), 1053endothelin-induced contractions, pinaci-
dil antagonism (guinea pigs, rats),1318
esophageal longitudinal, bradykinin effect(opossums), 1012
inositol phosphate production, effect ofH-7, crossbrdige phosphorylation(rabbits), 253
lower esophageal sphincter relaxation,cAMP-dependent protein kinase
(dogs), 1160mesenteric artery, sensitivity, calcium an-
tagonists (rabbits), 1167
vascular, age-related changes in relaxant
response, atrial natriuretic peptide
(rats), 1234Mutlib, A. E. and Nelson, W. L.: Synthesis
and identification of the N-glucuro-nides of norgallopamil and norvera-
pamil, unusual metabolites of gallo-pamil and verapamil, 593
Myeloperoxidase, cardioprotective effects of
sodium nitrite, myocardial ischemia,reperfusion (cats), 35
Myenteric plexus, ablation, cholinergic sen-
sitivity, jejunal circular muscle (rats),
135
1990 Index 1397
Nervescalcitonin gene-related peptide-contain-
Myocardium, neutrophil function, lipoxy-genase inhibitors (humans), 531
Myocytes
modulation of automaticity, phospholi-pase C, cardiac Purkinje fibers (dogs),886
ventricular, electrophysiological effects,
metoprolol (cats), 1043
Myometrium, muscarinic receptor subtypes,
inositol phosphate generation, aden-
ylate cyclase inhibition (guinea pigs),800
Myosininositol phosphate production, effect of
H-7, crossbridge phosphorylation
(rabbits), 253
light chain phosphorylation, phorbol es-
tar-induced stress, carotid medial
smooth muscle (swine), 1068
Nagaya, H., Satoh, H. and Maki, Y.: Possi-ble mechanism for the inhibition of
acid formation by the proton pumpinhibitor AG-1749 in isolated canine
parietal cells, 1289Nahorski, S. R., see Chilvers, E. R., 786Nakao, K., see Okabe, K., 832Nakayama, K., see Yamada, S., 327, 765Nakazawa, T., Furuya, Y., Kaneko, T., Ya-
matsu, K., Yoshino, H. and Tachi-
bans, S.: Analgesia produced by E-2078, a systemically active dynorphin
analog, in mice, 1247
Naloxone
analgesia produced by E-2078 (mice),1247
blockade of voltage-dependent potassiumcurrents, phencyclidine, thymocytes
(mice), 610
Naltrexone
saline discrimination, opioid antagonists,
morphine (monkeys), 600
sensitivity to behavioral effects (rats), 8
Nandi, J., King, R. L., Kaplan, D. S. andLevine, R. A.: Mechanisms of gastric
proton pump inhibition by calciumchannel antagonists, 1102
Naphthalene, bronchiolar Clara cell necro-sis, metabolic activation, lung (mice),428
Narahashi, T., see Ogata, N., 1142
Natriuresis, modulation of renal response to
endothelin, cycbooxygenase products,
atrial natriuretic peptide (rats), 1213
Navarro, H. A., see Kudlacz, E. M., 42Nelson, D. L., see Killam, A. L., 1083
Nelson, S. D., see Kalhorn, T. F, 112Nelson, W. L., see Mutlib, A. E., 593
Neocortex, inhibition of norepinephrine andacetylcholine release, w-conotoxinGVIA (humans), 778
Neostigmine, rate perfusion pressure, sub-
stance P (guinea pigs), 179Nephrotic syndrome, response to furose-
mide-A mechanism, intratubular al-
bumin (rats), 1097
Nephrotoxicity, renal mitochondria, cepha-losporins (rabbits), 65
Nerme, V., Abrahamsson, T. and Vauquelin,
G.: Chronic isoproterenol adminis-tration causes altered beta adreno-ceptor-G.-coupling in guinea piglung, 1341
ing, vascular adrenergic neurotrans-
mission (rats), 403
drug-induced release of adenine nucleo-
sides, nucleotides, aorta (rabbits),
1060indomethacin effects on neural and my-
ogenic components, airway smoothmuscle (horses), 358
stimulation, ion transport, jejunum
(mice), 636Neuroblastoma
agonist-induced muscarinic receptor loss,
phosphoinositide turnover (humans),
744
blockade of increase in intracellular cal-cium, doxorubicin, 979
potent blocking action of chlorpromazine,
calcium channels (mice), 1142
Neurokinin A, tachykinin-induced anion se-
cretion, distal colon (guinea pigs), 1
Neurons
hippocampal, ethanol tolerance (rats),
265
mesoprefrontal dopamine, modulation,
central benzodiazepine receptors, 989
striatal, NMDA receptor system, evoked
GABA release (mice), 380Neurotensin, -induced dopamine release,
substantia nigra, nucleus caudate
(rabbits), 817
Neurotoxicity, glutamate, cerebellar granule
cells (rats), 419
Neurotoxins, cellular localization of sero-
tonin 1A,1B, uptake sites, cingulate
cortex (rats), 651Neurotransmission
adrenergic, electrophysiology, saphenousveins (dogs), 1197
enkephalinergic and GABAergic modula-
tion, motor activity, ventral pallidum
(rats), 1370
excitatory noncholinergic and cholinergic,potassium channel activator, airways(guinea pigs), 1207
vascular adrenergic, calcitonin gene-re-lated peptide-containing nerves
(rats), 403
Neurotransmitter, glycine-evoked release,hippocampus (rats), 574
Neutrophils, function, lipoxygenase inhibi-
tors (humans), 531
Neve, K. A., Henningsen, R. A., Kinzie, J.M., de Paulis T., Schmidt, D. E., Kes-sler, R. M. and Janowsky, A.: So-dium-dependent isomerization of do-
pamine D-2 receptors characterized
using [1�IIepidepride, a high-affinity
substituted benzamide ligand, 1108
Newman, M. E., Drummer, D. and Lerer,B.: Single and combined effects of
desimipramine and lithium on sero-
tonergic receptor number and second
messenger function in rat brain, 826
Ngai, J. H., Roth, P. 5. and Paul, R. J.:
Effects of endothelium on basal tone,agonist- and 02-sensitivity in porcine
coronary artery, 1053
Nicklaus, K. J., see Lee, W., 482
Nicolaci, J., see Drummer, 0. H., 1202Nicotine
acute effects on prolactin release (rats),
15
chronic administration, prolactin release
(rats), 21
effect of dose, withdrawal-suppression(humans), 1175
isobolographic characterization, drug in-
teractions, biological variability
(mice), 208role of fourth cerebroventricle, plasma
ACTH responses (rats), 623Nifedipine, gastric proton pump inhibition,
calcium channel antagonists (rab-bits), 1102
Niida, H., see Takeuchi, K., 1228Nikam, S. S., see Killam, A. L., 1083Nitrendipine, catamphiphilic drug uptake,
calcium displacement, erythrocytesand muscular tissue (humans), 333
Nitric oxide, endothelium-derived relaxing
factor, spectrophotometric and bio-logical assays, 922
Nociception, transmission of information inspinal cord, substance P and soma-
tostatin, formalin (mice), 1261Nook, B., see Cicero, T. J., 456
Noradrenalinerelease from adrenal chromaffin cells,
phosphoinositide turnover, cAMPaccumulation, 1296
sodium-dependent release of dopamine,brain synaptosomes (rats), 1283
Norepinephrineacetylcholine release and, inhibition from
neocortex, w-conotoxin GVIA (hu-mans), 778
arterial contraction and Rb-86 efflux,BRL-34915 (rats), 51
cocaine-mediated impairment, cardiacconduction (dogs), 185
inotropic response, prazosin-sensitivecomponent, heart (rabbits), 853
neurally released, potentiation of cardiac
effects, cocaine (cats), 147prejunctional modulation ofrelease, effect
ofage (rats), 159Norgallopamil, norverapamil and, N-glucu-
ronides, 593
Nucleus caudate, substantia nigra and, neu-
rotensin-induced dopamine release(rabbits), 817
Nuki, C., see Kawasaki, H., 403
Oakes, S. G., Schlager, J. J., Santone, K. S.,Abraham, R. T. and Powis, G.: Dox-orubicin blocks the increase in intra-
cellular Ca�, part of a second mes-
senger system in NIE-115 murineneuroblastoma cells, 979
O’Connor, L., see Cicero, T. J., 456O’Donnell, S. R., Wanstall, J. C. and Zeng,
X.-P.: Pinacidil antagonism of endo-thelin-induced contractions of
smooth muscle in the lungs: Differ-
ences between tracheal and pulmo-
nary artery preparations, 1318Ogata, H., see Takahashi, H., 272Ogata, N. and Narahashi, T.: Potent block-
ing action of chlorpromazine on twotypes of calcium channels in cultured
neuroblastoma cells, 11428-OH-DPAT, activation of ventral medul-
lary serotonin receptor subtypes, car-diovascular activity (cats), 665
Ohhashi, T., see Kawai, Y., 1234Ohkubo, T., Shibata, M., Takahashi, H. and
Inoki, R.: Roles of substance P andsomatostatin on transmission of no-
1398 Index Vol. 252
ciceptive information induced by for-maIm in spinal cord, 1261
Ohno, Y. and Warnick, J. E.: Selectivedepression of the segmental polysy-naptic reflex by phencyclidine and itsanalogs in the rat in Vitro: Interac-tion with N-methyl-D-aspartate re-
ceptors, 246Ohyama, T., , see Hayashi, K. 1240Okabe, K., Kajioka, S., Nakao, K., Kits-
mura, K., Kuriyama, H. and Weston,A. H.: Actions of cromakalim on ioniccurrents recorded from single smoothmuscle cells of the rat portal vein,832
Okabe, S., see Takeuchi, K., 1228Okada, M., Mine, K. and Fujiwara, M.: Na�-
dependent release of endogenous do-pamine and noradrenaline from ratbrain synaptosomes, 1283
Okada, M., see Takeuchi, K., 1228Okamura, T., see Teds, N., 374Okano, T., see Tomita, Y., 859Okita, G. T., see Rasmussen, H. H., 60Olley, P. M., see Adeagbo, A. S. 0., 875Opioids
agonists, thermoregulatory set point(rats), 696
antagonists, saline and naltrexone dis-crimination, morphine (monkeys),
600
differential cross-tolerance, shock titra-
tion schedule (monkeys), 845kappa, partial agonist activity, BW942C
(humans, rats, mice, monkeys), 225Ormsbee, H. S., I!!, see Barnette, M. S.,
1160Osnes, J.-B., see Skomedal, T., 853Oases, L., see Fiorica-Howells, E., 610Otterness, D. M., see Hernandez, J. 5., 568Overend, M. F., see Brown, D. R, 126Owen, P. J., see Plevin, R., 1296Oxmetidine, inhibition of liver mitochon-
drial respiration (rats), 908Oxygen
-dependent hepatotoxicity, ethyihexanol,mitochondria (rats), 1355
elevation of diphosphoglycerate level, 2,3-diphosphoglycerate phosphatase/synthase, red blood cells (humans),192
sensitivity, endothelium effects, coronaryartery (pigs), 1053
Oxytocin, phosphoinositide hydrolysis,renal epithelial cells, 552
Paakkari, I., see Paakkari, P., 235Paakkari, P., Paakari, I., Sirmen, A.-L and
Feuerstein, G.: Respiratory and lo-comotor stimulation by low doses ofdermorphin, a Mu1 receptor-me-diated effect, 235
Page, R D. and Yorio, T.: PGF2,, inhibitsacidification ins W secreting epithe-ha, 929
Pancreas, water and bicarbonate secretion,gabexate and camostat (dogs), 320
Pandian, M. R., see Elias, A. N., 384Pang, P. K. T., see Yang, M. C. M., 840Panoutsacopoulou, M., see Maragoudakis,
M. E., 753Parathyroid hormone
mechanisms of vascular action, 840peptide fragments, salmon calcitonin and
morphine, antinociceptive tests(mice), 140
Parietal cellscalcium channel antagonists, mecha-
nisms, gastric proton pump inhibi-
tion (rabbits), 1102inhibition of acid formation, AG-1749
(dogs), 1289Parini, A., see Coupry, I., 293Paroxetine, antidepressant binding sites in
brain (rats), 410Patch clamp
D2 dopamine receptors, calcium channelcurrent, adrenal chromaffin cells (bo-
vine), 586molecular effects of dimethylanatoxin,
peripheral nicotinic acetylchohine re-ceptor, 507
Patel, J., see Mangano, T. J., 574Paul, I. A., Duncan, G. E., Kuhn, C., Muel-
ler, R. A., Hong, J.-S. and Breese, G.R.: Neural adaptation in imipramine-treated rats processed in the forcedswim test: Assessment of time course,handling, rat strain and amine up-take, 997
Paul, R. J., see Ngai, J. H., 1053PC 12 cells, chronic ethanol exposure, aden-
ylate cyclase activity, cAMP content,1021
Peach, M. J., see Tracey, W. R., 922Pegram, B. L., see Scheufler, E., 333Pendleton, R. G., see Yu, K. T., 192Pendley, C., II, see Yu, K. T., 192Peptidases, peptide transport and, renal
brush-border membrane vesicles(rats), 98
Peptides, fragments of parathyroid hor-mone, salmon calcitonin and mor-phine, antinociceptive tests (mice),140
Peptidoleukotrienes, contractile responses,IC! 204,219 blockade, epithehium(guinea pigs), 77
Perico, N., Dadan, J., Gabanelli, M. and
Remuzzi, G.: Cycbooxygenase prod-
ucts and atrial natriuretic peptide
modulate renal response to endothe-lin, 1213
Perindopril, biliary excretion and conjuga-tion (rats), 1202
Perrone, M. H., see Bilder, G. E., 526Persson, C. G. A., see Karlsson, J.-A., 863Pertussis toxin
inhibition of contractions but not relaxa-tions, acetylcholine, pulmonary ar-tery (rabbits), 260
interaction of azepexole and halothane(guinea pigs), 1156
Peters, T., see Scheufler, E., 333Peterson, P. K., see Chao, C. C., 605pH
gastric alkaline secretion, influence ofstress (rats), 1228
inhibition of acidification, W-secretingepithelia, prostaglandin F� (frogs),929
Phencychidine
blockade of voltage-dependent potassiumcurrents, thymocytes (mice), 610
depression, segmental polysynaptic reflex(rats), 246
discriminative stimulus properties, self-
administration, MK-801 (monkeys),953
-like behavioral effec